First Case of Encephalitis Linked to COVID-19 Reported

A 58-year-old woman with COVID-19 and altered mental state was diagnosed with acute necrotizing encephalopathy.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 23 May 2020Source: Brain, Behavior, and ImmunityAuthor(s): Adelaide Panariello, Roberta Bassetti, Anna Radice, Roberto Rossotti, Massimo Puoti, Matteo Corradin, Mauro Moreno, Mauro Percudani
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
Abstract COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at...
Source: Accident and Emergency Nursing - Category: Emergency Medicine Authors: Tags: Arch Acad Emerg Med Source Type: research
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the cause of the current pandemic coronavirus disease 2019 (COVID-19), primarily targets the respiratory system. Some patients also experience neurological signs and symptoms ranging from anosmia, ageusia, headache, nausea, and vomiting to confusion, encephalitis, and stroke. Approximately 36% of those with severe COVID-19 experience neurological complications. The virus may enter the central nervous system through the olfactory nerve in the nasal cavity and damage neurons in the brainstem nuclei involved in the regulation of respiration. Patients with cerebe...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Conclusion: The neurological manifestations associated with COVID-19 such as Encephalitis, Meningitis, acute cerebrovascular disease, and Guillain Barré Syndrome (GBS) are of great concern. But in the presence of life-threatening abnormal vitals in severely ill COVID-19 patients, these are not usually underscored. There is a need to diagnose these manifestations at the earliest to limit long term sequelae. Much research is needed to explore the role of SARS-CoV-2 in causing these neurological manifestations by isolating it either from cerebrospinal fluid or brain tissues of the deceased on autopsy. We also recommend...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Conclusions: Neurologic manifestations in COVID-19 may alert physicians and medical practitioners to rule in high-risk patients. The increasing incidence of olfactory/taste disorders, myalgia, headache, and acute cerebral vascular disease renders a possibility that COVID-19 could attack the nervous system. The cytokine secretion and bloodstream circulation (viremia) are among the most possible routes into the nervous system.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Publication date: Available online 6 May 2020Source: Brain, Behavior, and ImmunityAuthor(s): Y. Hanna Huang, Daniel Jiang, Jong T. Huang
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
ConclusionsDuring the current viral outbreak, physicians should not neglect the possibility of other diseases that represent neurological emergencies and require immediate recognition and treatment.
Source: Neurological Sciences - Category: Neurology Source Type: research
Publication date: Available online 6 May 2020Source: Brain, Behavior, and ImmunityAuthor(s): Y. Hanna Huang, Daniel Jiang, Jong T. Huang
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
PMID: 32387508 [PubMed - as supplied by publisher]
Source: Brain, Behavior, and Immunity - Category: Neurology Authors: Tags: Brain Behav Immun Source Type: research
The neurotropic potential and the neurological complications of coronavirus disease (COVID-19) are still being uncovered, those documented so far include headaches, acute cerebrovascular incidents, anosmia, post-infectious disseminated and brainstem encephalitis and viral meningitis [1] and Guillain-Barr é Syndrome [2]. Myasthenia gravis (MG) patients are particularly susceptible to infections causing crises due to the combination of reduced neuromuscular safety factors adversely affected by pyrexia and the effect of acute inflammatory mediators compounded by immunosuppression in many patients [3,4 ].
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Letter to the Editor Source Type: research
More News: COVID-19 | Encephalitis | Health | Men